4.6 Review

Contemporary genetic technologies and female reproduction

Journal

HUMAN REPRODUCTION UPDATE
Volume 17, Issue 6, Pages 829-847

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/humupd/dmr033

Keywords

genes and female reproductive pathologies; embryo assessment; endometriosis; metabolomics; transcriptomics

Funding

  1. Merck Serono S.A., Geneva, Switzerland
  2. Andromed
  3. Ardana
  4. Ferring Pharmaceuticals
  5. Genovum
  6. Glycotope
  7. Merck Serono
  8. MSD
  9. Organon
  10. Pantarhei Bioscience
  11. Philips
  12. PregLem
  13. Schering
  14. Schering-Plough
  15. Serono
  16. Wyeth

Ask authors/readers for more resources

BACKGROUND: The Fifth Evian Annual Reproduction (EVAR) Workshop Meeting discussed knowledge regarding contemporary genetics in female reproduction. METHODS: Specialist reproductive medicine clinicians and geneticists delivered presentations based on published literature and current research. The content of this report is based on the expert presentations and subsequent group discussions that took place during this Workshop. RESULTS: Numerous ovarian genes with a role in infertility have been identified. Future challenges for genetic screening of patients, such as those with polycystic ovary syndrome, primary ovarian insufficiency or endometriosis, include the identification of high-throughput strategies and how to apply these findings to infertile patients. The identification of high-quality embryos in IVF using objective technologies remains a high priority in order to facilitate single-embryo transfer. Gene expression profiling of cumulus cells surrounding the oocyte, and proteomic and metabolomic approaches in embryo culture media may significantly improve non-invasive embryo quality assessment. CONCLUSIONS: The way forward in advancing the knowledge of genes involved in reproduction was considered to be through genome-wide association studies involving large numbers of patients. Establishing international collaboration is required to enable the application of such technologies in sufficient numbers of patients.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available